Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Epizyme, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/09/2022 | Q2 2022 | -$0.36 | -$0.25 | 0.11 | N/A | $27.53 M |
| 05/10/2022 | Q1 2022 | -$0.35 | -$0.38 | -0.03 | N/A | $8.70 M |
| 03/01/2022 | Q4 2021 | N/A | -$0.49 | N/A | N/A | $11.58 M |
| 11/09/2021 | Q3 2021 | -$0.48 | -$0.64 | -0.16 | N/A | $5.20 M |
| 08/09/2021 | Q2 2021 | -$0.62 | -$0.63 | -0.01 | N/A | $13.01 M |
| 05/06/2021 | Q1 2021 | -$0.57 | -$0.69 | -0.12 | N/A | $7.63 M |
| 02/23/2021 | Q4 2020 | -$0.58 | -$0.65 | -0.07 | N/A | $8.38 M |
| 11/06/2020 | Q3 2020 | -$0.60 | -$0.55 | 0.05 | N/A | $3.57 M |
| 08/04/2020 | Q2 2020 | -$0.61 | -$0.58 | 0.03 | N/A | $2.47 M |
| 05/04/2020 | Q1 2020 | -$0.74 | -$0.51 | 0.23 | N/A | $1.35 M |
| 02/27/2020 | Q4 2019 | N/A | -$0.59 | N/A | N/A | $4.29 M |
| 10/31/2019 | Q3 2019 | N/A | -$0.40 | N/A | N/A | $5.72 M |
| 08/09/2019 | Q2 2019 | -$0.53 | -$0.53 | 0 | N/A | $5.90 M |
| 05/06/2019 | Q1 2019 | -$0.46 | -$0.36 | 0.1 | N/A | $7.89 M |
| 02/26/2019 | Q4 2018 | -$0.47 | -$0.29 | 0.18 | N/A | $9.70 M |
| 11/02/2018 | Q3 2018 | -$0.61 | -$0.54 | 0.07 | N/A | $0 |
| 08/02/2018 | Q2 2018 | -$0.51 | -$0.42 | 0.09 | N/A | $12.00 M |
| 05/08/2018 | Q1 2018 | -$0.55 | -$0.49 | 0.06 | N/A | $0 |
| 03/13/2018 | Q4 2017 | -$0.57 | -$0.60 | -0.03 | N/A | $0 |
| 11/01/2017 | Q3 2017 | -$0.64 | -$0.63 | 0.01 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Epizyme, Inc. Earnings: FAQ's
Epizyme, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 9th, 2022 based offlast year's report dates.
In the previous quarter, Epizyme, Inc. (:EPZM) reported $-0.21 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.36 by $0.15.
The conference call for Epizyme, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Epizyme, Inc.'s latest earnings report can be read online.
Epizyme, Inc. (:EPZM) has a recorded annual revenue of $37.43 M.
Epizyme, Inc. (:EPZM) has a recorded net income of $-251,122,000.Epizyme, Inc. has generated $-2.49 earnings per share over the last four quarters.
Epizyme, Inc. (:EPZM) has a price-to-earnings ratio of -0.59 and price/earnings-to-growth ratio is -0.01.